Medicare Program; Solicitation for Proposals for the Medicare Imaging Demonstration, 43178-43180 [2010-18139]
Download as PDF
43178
Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
Organ Procurement Organizations
(OPOs) are not-for-profit organizations
that are responsible for the
procurement, preservation, and
transport of transplantable organs to
transplant centers throughout the
country. Qualified OPOs are designated
by the Centers for Medicare & Medicaid
Services (CMS) to recover or procure
organs in CMS-defined exclusive
geographic service areas, pursuant to
section 371(b)(1) of the Public Health
Service Act (42 U.S.C. 273(b)(1)) and
our regulations at 42 CFR 486.306. Once
an OPO has been designated for an area,
hospitals in that area that participate in
Medicare and Medicaid are required to
work with that OPO in providing organs
for transplant, pursuant to section
1138(a)(1)(C) of the Social Security Act
(the Act) and our regulations at 42 CFR
482.45.
Section 1138(a)(1)(A)(iii) of the Act
provides that a hospital must notify the
designated OPO (for the service area in
which it is located) of potential organ
donors. Under section 1138(a)(1)(C) of
the Act, every participating hospital
must have an agreement to identify
potential donors only with its
designated OPO.
However, section 1138(a)(2)(A) of the
Act provides that a hospital may obtain
a waiver of the above requirements from
the Secretary under certain specified
conditions. A waiver allows the hospital
to have an agreement with an OPO other
than the one initially designated by
CMS, if the hospital meets certain
conditions specified in section
1138(a)(2)(A) of the Act. In addition, the
Secretary may review additional criteria
described in section 1138(a)(2)(B) of the
Act to evaluate the hospital’s request for
a waiver.
Section 1138(a)(2)(A) of the Act states
that in granting a waiver, the Secretary
must determine that the waiver—(1) is
expected to increase organ donations;
and (2) will ensure equitable treatment
of patients referred for transplants
VerDate Mar<15>2010
15:15 Jul 22, 2010
Jkt 220001
within the service area served by the
designated OPO and within the service
area served by the OPO with which the
hospital seeks to enter into an
agreement under the waiver. In making
a waiver determination, section
1138(a)(2)(B) of the Act provides that
the Secretary may consider, among
other factors: (1) Cost-effectiveness; (2)
improvements in quality; (3) whether
there has been any change in a
hospital’s designated OPO due to the
changes made in definitions for
metropolitan statistical areas; and (4)
the length and continuity of a hospital’s
relationship with an OPO other than the
hospital’s designated OPO. Under
section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice
of any waiver application received from
a hospital within 30 days of receiving
the application, and to offer interested
parties an opportunity to comment in
writing during the 60-day period
beginning on the publication date in the
Federal Register.
The criteria that the Secretary uses to
evaluate the waiver in these cases are
the same as those described above under
sections 1138(a)(2)(A) and (B) of the Act
and have been incorporated into the
regulations at § 486.308(e) and (f).
II. Waiver Request Procedures
In October 1995, we issued a Program
Memorandum (Transmittal No. A–95–
11) detailing the waiver process and
discussing the information hospitals
must provide in requesting a waiver. We
indicated that upon receipt of a waiver
request, we would publish a Federal
Register notice to solicit public
comments, as required by section
1138(a)(2)(D) of the Act.
According to these requirements, we
will review the request and comments
received. During the review process, we
may consult on an as-needed basis with
the Health Resources and Services
Administration’s Division of
Transplantation, the United Network for
Organ Sharing, and our regional offices.
If necessary, we may request additional
clarifying information from the applying
hospital or others. We will then make a
final determination on the waiver
request and notify the hospital and the
designated and requested OPOs.
III. Hospital Waiver Requests
As permitted by § 486.308(e), the
following hospital has requested a
waiver in order to enter into an
agreement with a designated OPO other
than the OPO designated for the service
area in which the hospital is located:
Stafford Hospital (Medicare provider
number 49–0140), of Stafford, Virginia,
is requesting a waiver to work with:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
LifeNet Health, 1864 Concert Drive,
Virginia Beach, VA 23453.
The Hospital’s Designated OPO is:
Washington Regional Transplant
Consortium, 7619 Little River
Turnpike, Suite 900, Annandale, VA
22002.
IV. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; Program No. 93.774, Medicare—
Supplementary Medical Insurance, and
Program No. 93.778, Medical Assistance
Program)
Dated: July 15, 2010.
Marilyn Tavenner,
Principal Deputy Administrator and Chief
Operating Officer, Centers for Medicare &
Medicaid Services.
[FR Doc. 2010–18137 Filed 7–22–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–5047–N]
Medicare Program; Solicitation for
Proposals for the Medicare Imaging
Demonstration
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice informs interested
parties (here in there after referred to as
conveners) of an opportunity to apply to
participate in the Medicare Imaging
Demonstration (MID) that was
authorized by section 135(b) of the
Medicare Improvements for Patients and
Providers Act of 2008 (MIPPA). The goal
of the MID is to collect data regarding
physician compliance with
appropriateness criteria selected by the
Secretary under the terms of the statute
in order to determine the
appropriateness of advanced diagnostic
imaging services furnished to Medicare
beneficiaries.
DATES: Proposals will be considered
timely if they are received on or before
5 p.m., Eastern Standard Time (E.S.T.)
on September 21, 2010.
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices
Proposals should be mailed
to the following address: Centers for
Medicare & Medicaid Services,
Attention: Linda R. Lebovic, 7500
Security Boulevard, Mail Stop: C4–17–
27, Baltimore, Maryland 21244–1850.
FOR FURTHER INFORMATION CONTACT:
Linda R. Lebovic at (410) 786–3402 or
by e-mail at
ImagingDemo135b@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
General Information: Please refer to
file code [CMS–5047–N] on the
application. Proposals (an unbound
original and 3 copies plus an electronic
copy on CD–ROM) must be typed for
clarity and should not exceed 40
double-spaced pages, exclusive of cover
letter, the executive summary, resumes,
forms, and supporting documentation.
Because of staffing and resource
limitations, we cannot accept proposals
by facsimile (FAX) transmission.
Applicants may, but are not required to,
submit a total of 10 copies to assure that
each reviewer receives a proposal in the
manner intended by the applicant (for
example, collated, tabulated color
copies). Hard copies and electronic
copies must be identical.
Eligible Organizations: CMS
anticipates that a wide variety of
interested parties may be eligible to
apply as conveners or in collaboration
with other organizations to perform the
responsibilities specified. Examples of
conveners include, but are not limited
to, medical specialty societies,
physician groups, integrated health care
delivery systems, independent practice
associations, radiology benefit
managers, health plans, information
technology vendors, and collaborations
among the above parties.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
ADDRESSES:
I. Provisions of This Notice
This notice informs interested parties
(here in there after referred to as
conveners) of an opportunity to apply to
participate in the Medicare Imaging
Demonstration (MID) that was
authorized by section 135(b) of the
Medicare Improvements for Patients and
Providers Act of 2008 (MIPPA). The goal
of the MID is to collect data regarding
physician compliance with
appropriateness criteria selected by the
Secretary under the terms of the statute
in order to determine the
appropriateness of advanced diagnostic
imaging services furnished to Medicare
beneficiaries. The authorizing
legislation allows the Secretary to
include in the demonstration advanced
diagnostic imaging services such as
those defined in § 1834(e)(1)(B) of the
Social Security Act (the Act): Diagnostic
magnetic resonance imaging (MRI),
VerDate Mar<15>2010
15:15 Jul 22, 2010
Jkt 220001
computed tomography (CT), nuclear
medicine (including positron emission
tomography) and such other diagnostic
imaging services, including services
described in § 1848(b)(4)(B) of the Act
(excluding X-ray, ultrasound, and
fluoroscopy), as specified by the
Secretary in consultation with physician
specialty organizations and other
stakeholders. The law requires that the
appropriateness criteria used in the
demonstration be based on those
developed or endorsed by medical
specialty societies. The Centers for
Medicare & Medicaid Services (CMS)
worked with medical specialty societies
and other stakeholders, including the
AQA Alliance, to get their input and
information on available
appropriateness criteria. For purposes of
this demonstration, the ‘‘appropriateness
criteria’’ referenced in the statute will be
published medical specialty society
guidelines relevant to the 11 procedures
studied in the demonstration that are
developed or endorsed by relevant
medical specialty societies, are
consistent with the spirit of section
135(b)(2)(B)(ii)(II), and which have been
selected by the Secretary under the
terms of the statute. (We believe the
appropriateness criteria are the product
of consensus and meet the spirit of
section 135(b)(2)(B)(ii)(II) of MIPPA.
Consequently, published medical
specialty society guidelines relevant for
the 11 procedures are included in the
demonstration.
The law prohibits the use of prior
authorization in the demonstration. The
design of the demonstration will permit
evaluation of the appropriateness of
imaging services across a range of
advanced diagnostic imaging studies,
geographic areas, demographic
characteristics and practice settings
(such as private and academic practices)
in the Medicare fee-for-service program.
CMS is seeking participation by 2,500 to
3,500 physicians from 500 to 650
physician practices that vary in size,
specialty mix, type (academic and
private practice), and location (urban,
rural, and suburban) to obtain
substantial sample size for the
evaluation.
The demonstration will test whether
the use of decision support systems
(DSSs) can improve quality of care and
reduce unnecessary radiation exposure
and utilization by promoting
appropriate ordering of advanced
diagnostic imaging services. Physician
practices will receive feedback on the
degree of appropriateness relative to the
specified medical specialty society
guidelines used under the
demonstration.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
43179
CMS is seeking conveners that can
provide a panel of participating
physician practices that agree to use an
advanced diagnostic imaging DSS for
purposes of this demonstration. The
Secretary has chosen to use conveners
as a vehicle to recruit physician
practices for participation in the
demonstration because it is expected
that the likely applicants for the
convener have well developed
relationships (or the ability to establish)
with a significant network of physicians
that could be potential applicants for
participation in the demonstration.
Therefore, conveners would be highly
effective at providing a robust panel of
physicians that could satisfy the
selection requirements outlined in the
statute. The convener will secure a DSS
for advanced diagnostic imaging
services that will remain current with
the medical specialty society guidelines
used under the demonstration, recruit
physician practices, and make the DSS
available to physician practices
participating in the demonstration.
Through the DSS, a convener will
collect data on physician ordering of the
specified services and test results, and
provide feedback to physicians on
ordering appropriateness. The convener
will also distribute payments (as
determined by CMS) to the participating
practices for reporting data. In this
capacity, the convener will be
responding to the solicitation on its
behalf as applicant. For the
demonstration, interested parties may
need to collaborate as a convener in
order to have a panel of participating
physician practices, the availability of
the DSS for use by the physician
practices, and must comply with
demonstration requirements.
A competitive process will be used to
select conveners. CMS anticipates
selecting up to six conveners to
participate in the 2-year demonstration.
CMS is aware that certain arrangements
under this demonstration could raise
possible fraud, waste, and abuse
concerns, including concerns under the
anti-kickback statute and the physician
self-referral law. While CMS has the
authority to waive the application of
certain fraud, waste, and abuse laws, it
is anticipated that doing so, if at all, will
only occur after evaluating the
provisions of the proposals on a case-bycase basis and considering whether a
waiver is necessary to carry out the
demonstration project.
Physician practices must apply
through a convener and the convener’s
application must include the criteria
and rationale for recruiting physician
practices and obtaining their buy-in for
the use of the DSS. The Secretary has
E:\FR\FM\23JYN1.SGM
23JYN1
43180
Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices
chosen to use conveners as a vehicle to
recruit physician practices for
participation in the demonstration
because it is expected that the likely
applicants for the convener have well
developed relationships (or the ability
to establish) with a significant network
of physicians that could be potential
applicants for participation in the
demonstration. Therefore, conveners
would be highly effective at providing a
robust panel of physicians that could
satisfy the selection requirements
outlined in the statute. Conveners must
also disclose in the application whether
the DSS may be retained by the
participating practice after the
demonstration is concluded and
whether the DSS may be used to order
items and services other than the subject
imaging services.
Applicants must submit their
applications in the standard format
outlined in CMS’ Medicare Waiver
Demonstration Application and MID
solicitation in order to be considered for
review by the technical review panel.
Applications not received in this format
will not be considered for review.
The Medicare Waiver Demonstration
Application can be found electronically
at: https://www.cms.hhs.gov/cmsforms/
downloads/cms10069.pdf.
For specific details regarding the MID,
please refer to the solicitation on the
CMS Web site at: https://www.cms.hhs.
gov/DemoProjectsEvalRpts/downloads/
Medicare_Imaging_Demonstration.pdf.
II. Collection of Information
Requirements
Section 135(b)(4)(A) of the MIPPA
(Pub. L. 110–275) exempts this
demonstration from the Chapter 35 of
Title 44 of the United States Code;
however, the collection form entitled
‘‘Medicare Demonstration Waiver
Application’’ is currently approved
under OMB control number 0938–0880.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Research Centers in Trauma, Burn,
and Peri-Operative Injury (P50).
Date: August 17, 2010.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Natcher Building, 45 Center Drive,
Room 3AN12B, Bethesda, MD 20892.
Contact Person: Margaret J. Weidman, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892, 301–594–3663,
weidmanma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: July 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: April 1, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010–18088 Filed 7–22–10; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2010–18139 Filed 7–22–10; 8:45 am]
BILLING CODE 4120–01–P
VerDate Mar<15>2010
15:15 Jul 22, 2010
Jkt 220001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates (All
times are Eastern Time):
8:15 a.m.–3 p.m., August 10, 2010.
8:15 a.m.–4:15 p.m., August 11, 2010.
8:15 a.m.–12 p.m., August 12, 2010.
Public Comment Times and Dates (All times
are Eastern Time):
3:30 p.m.–5 p.m.,* August 10, 2010.
4:30 p.m.–6 p.m.,* August 11, 2010.
* Please note that the public comment
periods may end before the times indicated,
following the last call for comments.
Members of the public who wish to provide
public comment should plan to attend public
comment sessions at the start times listed.
Place: Shilo Inn Suites Hotel, 780 Lindsay
Blvd., Idaho Falls, Idaho; Phone: 208–523–
0088; Fax: 208–522–7420. Audio Conference
Call via FTS Conferencing. The USA toll free
dial in number is 1–866–659–0537 with a
pass code of 9933701.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
E:\FR\FM\23JYN1.SGM
23JYN1
Agencies
[Federal Register Volume 75, Number 141 (Friday, July 23, 2010)]
[Notices]
[Pages 43178-43180]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-5047-N]
Medicare Program; Solicitation for Proposals for the Medicare
Imaging Demonstration
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice informs interested parties (here in there after
referred to as conveners) of an opportunity to apply to participate in
the Medicare Imaging Demonstration (MID) that was authorized by section
135(b) of the Medicare Improvements for Patients and Providers Act of
2008 (MIPPA). The goal of the MID is to collect data regarding
physician compliance with appropriateness criteria selected by the
Secretary under the terms of the statute in order to determine the
appropriateness of advanced diagnostic imaging services furnished to
Medicare beneficiaries.
DATES: Proposals will be considered timely if they are received on or
before 5 p.m., Eastern Standard Time (E.S.T.) on September 21, 2010.
[[Page 43179]]
ADDRESSES: Proposals should be mailed to the following address: Centers
for Medicare & Medicaid Services, Attention: Linda R. Lebovic, 7500
Security Boulevard, Mail Stop: C4-17-27, Baltimore, Maryland 21244-
1850.
FOR FURTHER INFORMATION CONTACT: Linda R. Lebovic at (410) 786-3402 or
by e-mail at ImagingDemo135b@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
General Information: Please refer to file code [CMS-5047-N] on the
application. Proposals (an unbound original and 3 copies plus an
electronic copy on CD-ROM) must be typed for clarity and should not
exceed 40 double-spaced pages, exclusive of cover letter, the executive
summary, resumes, forms, and supporting documentation. Because of
staffing and resource limitations, we cannot accept proposals by
facsimile (FAX) transmission. Applicants may, but are not required to,
submit a total of 10 copies to assure that each reviewer receives a
proposal in the manner intended by the applicant (for example,
collated, tabulated color copies). Hard copies and electronic copies
must be identical.
Eligible Organizations: CMS anticipates that a wide variety of
interested parties may be eligible to apply as conveners or in
collaboration with other organizations to perform the responsibilities
specified. Examples of conveners include, but are not limited to,
medical specialty societies, physician groups, integrated health care
delivery systems, independent practice associations, radiology benefit
managers, health plans, information technology vendors, and
collaborations among the above parties.
I. Provisions of This Notice
This notice informs interested parties (here in there after
referred to as conveners) of an opportunity to apply to participate in
the Medicare Imaging Demonstration (MID) that was authorized by section
135(b) of the Medicare Improvements for Patients and Providers Act of
2008 (MIPPA). The goal of the MID is to collect data regarding
physician compliance with appropriateness criteria selected by the
Secretary under the terms of the statute in order to determine the
appropriateness of advanced diagnostic imaging services furnished to
Medicare beneficiaries. The authorizing legislation allows the
Secretary to include in the demonstration advanced diagnostic imaging
services such as those defined in Sec. 1834(e)(1)(B) of the Social
Security Act (the Act): Diagnostic magnetic resonance imaging (MRI),
computed tomography (CT), nuclear medicine (including positron emission
tomography) and such other diagnostic imaging services, including
services described in Sec. 1848(b)(4)(B) of the Act (excluding X-ray,
ultrasound, and fluoroscopy), as specified by the Secretary in
consultation with physician specialty organizations and other
stakeholders. The law requires that the appropriateness criteria used
in the demonstration be based on those developed or endorsed by medical
specialty societies. The Centers for Medicare & Medicaid Services (CMS)
worked with medical specialty societies and other stakeholders,
including the AQA Alliance, to get their input and information on
available appropriateness criteria. For purposes of this demonstration,
the ``appropriateness criteria'' referenced in the statute will be
published medical specialty society guidelines relevant to the 11
procedures studied in the demonstration that are developed or endorsed
by relevant medical specialty societies, are consistent with the spirit
of section 135(b)(2)(B)(ii)(II), and which have been selected by the
Secretary under the terms of the statute. (We believe the
appropriateness criteria are the product of consensus and meet the
spirit of section 135(b)(2)(B)(ii)(II) of MIPPA. Consequently,
published medical specialty society guidelines relevant for the 11
procedures are included in the demonstration.
The law prohibits the use of prior authorization in the
demonstration. The design of the demonstration will permit evaluation
of the appropriateness of imaging services across a range of advanced
diagnostic imaging studies, geographic areas, demographic
characteristics and practice settings (such as private and academic
practices) in the Medicare fee-for-service program. CMS is seeking
participation by 2,500 to 3,500 physicians from 500 to 650 physician
practices that vary in size, specialty mix, type (academic and private
practice), and location (urban, rural, and suburban) to obtain
substantial sample size for the evaluation.
The demonstration will test whether the use of decision support
systems (DSSs) can improve quality of care and reduce unnecessary
radiation exposure and utilization by promoting appropriate ordering of
advanced diagnostic imaging services. Physician practices will receive
feedback on the degree of appropriateness relative to the specified
medical specialty society guidelines used under the demonstration.
CMS is seeking conveners that can provide a panel of participating
physician practices that agree to use an advanced diagnostic imaging
DSS for purposes of this demonstration. The Secretary has chosen to use
conveners as a vehicle to recruit physician practices for participation
in the demonstration because it is expected that the likely applicants
for the convener have well developed relationships (or the ability to
establish) with a significant network of physicians that could be
potential applicants for participation in the demonstration. Therefore,
conveners would be highly effective at providing a robust panel of
physicians that could satisfy the selection requirements outlined in
the statute. The convener will secure a DSS for advanced diagnostic
imaging services that will remain current with the medical specialty
society guidelines used under the demonstration, recruit physician
practices, and make the DSS available to physician practices
participating in the demonstration. Through the DSS, a convener will
collect data on physician ordering of the specified services and test
results, and provide feedback to physicians on ordering
appropriateness. The convener will also distribute payments (as
determined by CMS) to the participating practices for reporting data.
In this capacity, the convener will be responding to the solicitation
on its behalf as applicant. For the demonstration, interested parties
may need to collaborate as a convener in order to have a panel of
participating physician practices, the availability of the DSS for use
by the physician practices, and must comply with demonstration
requirements.
A competitive process will be used to select conveners. CMS
anticipates selecting up to six conveners to participate in the 2-year
demonstration. CMS is aware that certain arrangements under this
demonstration could raise possible fraud, waste, and abuse concerns,
including concerns under the anti-kickback statute and the physician
self-referral law. While CMS has the authority to waive the application
of certain fraud, waste, and abuse laws, it is anticipated that doing
so, if at all, will only occur after evaluating the provisions of the
proposals on a case-by-case basis and considering whether a waiver is
necessary to carry out the demonstration project.
Physician practices must apply through a convener and the
convener's application must include the criteria and rationale for
recruiting physician practices and obtaining their buy-in for the use
of the DSS. The Secretary has
[[Page 43180]]
chosen to use conveners as a vehicle to recruit physician practices for
participation in the demonstration because it is expected that the
likely applicants for the convener have well developed relationships
(or the ability to establish) with a significant network of physicians
that could be potential applicants for participation in the
demonstration. Therefore, conveners would be highly effective at
providing a robust panel of physicians that could satisfy the selection
requirements outlined in the statute. Conveners must also disclose in
the application whether the DSS may be retained by the participating
practice after the demonstration is concluded and whether the DSS may
be used to order items and services other than the subject imaging
services.
Applicants must submit their applications in the standard format
outlined in CMS' Medicare Waiver Demonstration Application and MID
solicitation in order to be considered for review by the technical
review panel. Applications not received in this format will not be
considered for review.
The Medicare Waiver Demonstration Application can be found
electronically at: https://www.cms.hhs.gov/cmsforms/downloads/cms10069.pdf.
For specific details regarding the MID, please refer to the
solicitation on the CMS Web site at: https://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/Medicare_Imaging_Demonstration.pdf.
II. Collection of Information Requirements
Section 135(b)(4)(A) of the MIPPA (Pub. L. 110-275) exempts this
demonstration from the Chapter 35 of Title 44 of the United States
Code; however, the collection form entitled ``Medicare Demonstration
Waiver Application'' is currently approved under OMB control number
0938-0880.
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: April 1, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2010-18139 Filed 7-22-10; 8:45 am]
BILLING CODE 4120-01-P